Overview Beta Blocker for Chronic Wound Healing Status: Terminated Trial end date: 2007-06-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of treatment of chronic cutaneous ulcers and burn wounds with topical beta adrenergic antagonists (Timoptic®). Phase: Phase 2 Details Lead Sponsor: University of California, DavisTreatments: Adrenergic AgentsAdrenergic AntagonistsAdrenergic beta-AntagonistsTimolol